Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.3611
|
0.37
|
0.366
|
0.36
|
0.376
|
0.361
|
|
|
30 299.84
|
269.00
|
0.365
|
0.369
|
0.365
|
0.35
|
0.3692
|
0.3683
|
|
|
170 534.82
|
705.00
|
0.36
|
0.37
|
0.367
|
0.356
|
0.3798
|
0.3614
|
|
|
82 591.10
|
435.00
|
0.371
|
0.38
|
0.3725
|
0.361
|
0.39
|
0.3646
|
|
|
49 487.87
|
385.00
|
0.36
|
0.38
|
0.377
|
0.36
|
0.3882
|
0.371
|
|
|
114 854.75
|
390.00
|
0.3701
|
0.38
|
0.411
|
0.363
|
0.4199
|
0.3761
|
|
|
135 543.62
|
479.00
|
0.4011
|
0.417
|
0.3959
|
0.393
|
0.4299
|
0.4101
|
|
|
90 500.20
|
379.00
|
0.3801
|
0.39
|
0.3698
|
0.3631
|
0.4099
|
0.4095
|
|
|
76 157.64
|
542.00
|
0.37
|
0.382
|
0.375
|
0.367
|
0.384
|
0.3702
|
|
|
35 235.50
|
206.00
|
0.3701
|
0.38
|
0.3867
|
0.361
|
0.3867
|
0.368
|
|
|
78 113.65
|
362.00
|
Tharimmune is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (IMCD) for drug resistant and devastating cancers.